Stoke Therapeutics is pioneering a new way to treat the underlying causes of severe genetic diseases by precisely upregulating protein expression.

Biotechnology

Stoke Therapeutics

Stoke Therapeutics' headquarters in Bedford, MA, United States

Edward M. Kaye

Omar Brahim

Rose Sun

Barbara Sutter

Barry S. Ticho

Isabel Aznarez

Jessica Blumstein

Malini Viswanathan Ph.D

Katherine Pare Lefeber

Joan Wood

Jason Hoitt

Jonathan Allan

Dawn Kalmar

Seth L. Harrison

Adrian Krainer

Garry E. Menzel

Arthur Levin

Julie Anne Smith

Arthur Tzianabos

Jennifer Burstein

The Research and Development team at Stoke Therapeutics is dedicated to advancing innovative therapies for severe genetic diseases by leveraging cutting-edge bioinformatics, medicinal chemistry, and in vitro pharmacology. This multidisciplinary group collaborates to design, test, and refine potential treatments, aiming to upregulate protein expression and address the root causes of these conditions, ultimately paving the way for transformative clinical applications.

Research and Development

The Clinical Operations team at Stoke Therapeutics is responsible for overseeing the planning, execution, and management of clinical trials aimed at evaluating innovative treatments for severe genetic diseases. This team ensures compliance with regulatory standards, coordinates logistics, manages clinical data, and collaborates across departments to facilitate efficient trial processes, ultimately driving the development of new therapies from concept to clinical implementation.

Clinical Operations

The Leadership Team at Stoke Therapeutics is responsible for setting the strategic direction of the company and ensuring the successful advancement of its mission to treat severe genetic diseases. This diverse team, composed of experts in medical research, operations, finance, and communications, collaborates to drive innovation, oversee clinical development, manage regulatory compliance, and foster stakeholder engagement, ultimately striving to bring transformative therapies to patients in need.

Leadership Team

The Clinical Operations team at Stoke Therapeutics is responsible for overseeing the execution and management of clinical trials. They ensure that studies are conducted efficiently and adhere to regulatory guidelines, while also managing data integrity and analysis. This team collaborates closely with medical and research professionals to drive the development of innovative treatments for genetic diseases, specifically focusing on ophthalmology and other therapeutic areas.

The Operations and Compliance team at Stoke Therapeutics plays a critical role in ensuring that the company's innovative approaches to treating genetic diseases are executed efficiently and adhere to all regulatory standards. This team is responsible for streamlining operational processes, overseeing compliance with Good Clinical Practice (GCP) regulations, and managing strategic initiatives that support both business growth and talent acquisition. Their collaborative efforts help maintain high-quality standards while driving the company's mission forward.

Operations and Compliance

The Research and Development team at Stoke Therapeutics drives innovative approaches to upregulate protein expression for treating severe genetic diseases. They collaborate on drug discovery and development, ensuring operational excellence in translational research and GMP quality, while strategically managing alliances and portfolios to advance therapeutic candidates from concept to clinical application.

Stoke Therapeutics

Org chart

Board & advisors

Teams

Research and Development

Clinical Operations

Leadership Team

Clinical Operations

Operations and Compliance

Research and Development

Offices

Stoke Therapeutics

Org chart

Board & advisors

Teams

Research and Development

Clinical Operations

Leadership Team

Clinical Operations

Operations and Compliance

Research and Development

Offices

Related companies